Pulmonology 1
Lifestyle interventions for asthma
Allergen control, weight loss, no smoking
COPD indication for systemic glucocorticoid
Acute COPD exacerbation
Diagnostic test for mesothelioma
Pleural biopsy
Most common cause of excessive daytime sleepiness
Insufficient sleep syndrome
Sarcoidosis management for asymptomatic patients without organ dysfunction
Observation
Treatment for poorly controlled asthma, elevated IgE, and allergies
Omalizumab
Add-on therapy to short-acting bronchodilators in COPD
LABA and/or LAMA
Number of pleural fluid cytology exams for maximum yield
Two
OSA symptom most responsive to treatment
Daytime sleepiness
Characteristics of idiopathic NSIP compared with IPF
Typically affects younger population, has more favorable prognosis
Asthma indication for adding LAMA
Poor control on glucocorticoid plus LABA
PDE-4 inhibitor to reduce severe COPD exacerbations, chronic bronchitis symptoms
Roflumilast
Pleural fluid enzyme test for TB
Adenosine deaminase
OHS defining parameter
Daytime hypercapnia
DPLD mimic of ARDS
Acute interstitial pneumonia
Noninvasive tool to quantify eosinophilic airway inflammation
Fractional exhaled nitric oxide test
Treatment for severe COPD
Triple inhaler therapy with LABA, LAMA, inhaled glucocorticoid
Most sensitive test for small pleural effusions while semirecumbent/supine
Ultrasonography
Primary risk factor for CSA
Heart failure
Antifibrotic therapy for progressive fibrotic CTD-ILD
Nintedanib or pirfenidone
Asthma monotherapy associated with increased mortality
LABA
Emphysema amenable to lung reduction surgery
Upper lobe predominant
Symptoms and history suggestive of mesothelioma
Asbestos exposure, chest pain, night sweats, recurrent pleural effusion
Conditions warranting in-lab polysomnography
Cardiopulmonary or neuromuscular disease
DPLD commonly associated with clubbing
Idiopathic pulmonary fibrosis